Live Interactive Webcast

 

Saturday, February 27, 2021
9:30 AM – 2:45 PM (ET)

This complimentary broadcast will offer up to 5.0 hours of AANP credits for nurse practitioners as well as 5.0 AMA PRA Category I Credits for physicians and physician assistants.

 

PROGRAM OVERVIEW

Integrity Continuing Education and Global Education Group together with our Nurse Practitioner national and state chapters partners, will launch the inaugural Nurse Practitioner Virtual Continuing Education Summit on February 27, 2021.  This innovative, multisupported, live webcast will provide an educational opportunity to meet the practical needs of nurse practitioners on the front lines of care. The program, moderated by Wendy Wright, MS, APRN, ANP-BC, FNP-BC, aims to deliver important educational updates by world-renowned clinical practitioners on conditions that are commonly encountered in both the primary care and specialty settings.

This years’ topics include the use of antiviral therapy in the management of influenza, best practices for reducing readmissions in patients with heart failure, improving early referral in pulmonary arterial hypertension, strategies to address patient education and adherence challenges in multiple sclerosis, and key updates in COVID-19.

EDUCATION PARTNERS

 

 

FACULTY

Program Moderator / Keynote Speaker:

Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP
Owner and Family Nurse Practitioner
Wright & Associates Family Healthcare, PLLC
Amherst, New Hampshire
Concord, New Hampshire

Faculty Presenters:

Denise Bruen, ANP-BC, MSN, MSCN
University of Virginia
James Q. Miller Consultative MS Center
Charlottesville, Virginia

Patricia K. Coyle, MD
Professor and Vice Chair, Clinical Affairs
Director, MS Comprehensive Care Center,
Stony Brook Medicine
Stony Brook, New York

Beth Towery Davidson, DNP, ACNP, CHFN, CCRN, FHFSA
Director, Heart Failure Disease Management
TriStar Centennial Medical Center
Adjunct Faculty, School of Nursing
Vanderbilt University
Nashville, Tennessee

Shashank Desai, MD
Heart Failure / Transplant
Inova Heart and Vascular Institute
Falls Church, VA

William A. Fischer II, MD
Associate Professor of Medicine
Division of Pulmonary and Critical Care Medicine
Institute of Global Health and Infectious Diseases
University of North Carolina School of Medicine
Chapel Hill, North Carolina

Martha Kingman, DNP FNP-C
Doctor of Nursing Practice
Pulmonary Hypertension Program
University of Texas Southwestern Medical Center
Dallas, Texas

Ryan Holley-Mallo, PhD, DNP, NP-C, FAANP
Nurse Practitioner
Catherine’s Health Center
Grand Rapids, Michigan

Vallerie V. McLaughlin, MD
Endowed Professor of Cardiovascular Medicine
Director of the Pulmonary Hypertension Program
University of Michigan
Ann Arbor, Michigan

AGENDA*

All times stated are in Eastern Time.
*Agenda is subject to change.

9:30 AM – 10:30 AM
Keynote: Evolving Recommendations regarding COVID-19: What You Need to Know

Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP
William A. Fischer II, MD

---

10:30 AM – 11:30 AM
Breaking Free from the Grasp of Seasonal Influenza: Key Diagnostic and Management Considerations on the Front Lines of Care

Ryan Holley-Mallo, PhD, DNP, NP-C, FAANP
William A. Fischer II, MD

---

11:30 AM – 12:30 PM
Effective Management of Patients with Heart Failure During and After the COVID-19 Pandemic

Beth Towery Davidson, DNP, ACNP, CHFN, CCRN, FHFSA
Shashank Desai, MD

---

12:30 PM – 12:45 PM
Intermission

---

12:45 PM – 1:45 PM
Raising the Index of Suspicion in Primary Care: Improving Referral Rates, Diagnosis and Outcomes in Pulmonary Hypertension

Martha Kingman, DNP FNP-C
Vallerie V. McLaughlin, MD

---

1:45 PM – 2:45 PM
Expanding the Role of the Nurse Practitioner in Multiple Sclerosis to Optimize Outcomes: Early Diagnosis, Treatment Advances, and Patient-Centered Care

Denise Bruen, ANP-BC, MSN, MSCN
Patricia K. Coyle, MD

---

 

TARGET AUDIENCE

This program has been designed for nurse practitioners, physicians, and physician assistants who practice in primary care and specialty settings.

LEARNING OBJECTIVES

Session 1 Keynote – Keynote: Evolving Recommendations regarding COVID-19: What You Need to Know

• Discuss the epidemiology, clinical features, differential diagnosis, and treatment of COVID-19.
• Identify patient populations at risk for severe COVID-19 disease.
• Explain COVID-19 transmission control practices for providers
• Review patient counseling to prevent household and community transmission of SARS-CoV-2 when infected/potentially infected.
• Review current and emerging pharmacotherapeutic prevention and treatment options for patients with COVID-19.

Session 2 – Breaking Free from the Grasp of Seasonal Influenza: Key Diagnostic and   Management Considerations on the Front Lines of Care

• Articulate the role of vaccination in reducing the spread of influenza and improving patient outcomes while emphasizing the importance during the COVID-19 pandemic
• Describe how to implement updated guidelines to differentially diagnose influenza in order to initiate early and appropriate therapy
• Discuss how to utilize antiviral chemoprophylaxis in appropriate individuals at risk high risk of developing influenza and associated complications
• Interpret existing and new evidence with traditional and new influenza treatments, including differences in efficacy and safety, dosage and administration, and reduction in disease burden and complications
• Outline how to individualize flu treatment with antiviral medications among diverse patients

Session 3 – Effective Management of Patients with Heart Failure During and After the COVID-19 Pandemic

• Explain the burden of COVID-19 on patients with cardiovascular disease (CVD) and related comorbidities
• Discuss the safety of RAAS antagonist use in patients with CVD and related comorbidities during the ongoing COVID-19 pandemic
• Outline how to apply evidence-based guideline-directed medical therapy (GDMT) into the management of patients with heart failure (HF)
• Discuss how to integrate telemedicine initiatives into the effective management of patients with HF

Session 4 – Raising the Index of Suspicion in Primary Care: Improving Referral Rates, Diagnosis and Outcomes in Pulmonary Hypertension

• Recognize the role for the nurse practitioner (NP) to improve patient outcomes in pulmonary arterial hypertension (PAH)
• Differentiate symptoms and signs of PAH from disorders with similar presentations to help improve early referral and recognition of the disease
• Discuss how to develop a patient-centered, guideline-directed, evidence-based management plan for PAH and chronic thromboembolic pulmonary hypertension that includes consideration of novel therapies and current clinical trial data

• Describe the patient experience for patients with PAH

Session 5 – Expanding the Role of the Nurse Practitioner in Multiple Sclerosis to Optimize Outcomes: Early Diagnosis, Treatment Advances, and Patient-Centered Care

• Define the role of the NPs in the primary care setting and their role in the diagnosis and treatment of multiple sclerosis (MS)
• Describe how to evaluate patients for signs and symptoms of early MS or relapse to facilitate prompt referral to specialist care
• Identify available therapies for treatment of MS and factors to consider in their use in individual patients
• Characterize strategies to address patient education and adherence challenges and the long-term monitoring of overall wellness in patients with MS

ACCREDITATION

Physician Continuing Education

Accreditation Statement
Integrity Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation
Integrity Continuing Education designates this free live activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioner Continuing Education

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Global Education Group and Integrity Continuing Education. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 5.0 contact hour(s) (which includes * hour(s) of pharmacology).

*Pharmacology hours are TBD after clinical content review.

INSTRUCTIONS TO RECEIVE CREDIT

In order to receive credit for this activity, the participant must complete each session’s pretest and posttest, view the live webcast, and complete the evaluation form. A statement of credit will be issued only upon receipt of a completed activity evaluation form.

FEE INFORMATION

There is no fee for this online live educational activity.

CONTACT INFORMATION

For information about ACCME accreditation of this activity, please contact Integrity Continuing Education at (855) 835-4004 or info@integrityce.com.

For information about AANP accreditation of this activity, please contact Global at (303) 395-1782 or cme@globaleducationgroup.com.

DISCLOSURE OF CONFLICTS OF INTEREST (COI)

Integrity Continuing Education and Global Education Group requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent COI they may have as related to the content of this activity. All identified COI are thoroughly vetted by Integrity Continuing Education and Global Education Group for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The following planners and managers (along with their spouses/life partners) reported no financial relationships nor relationships to products or devices with commercial interests related to the content of this CME activity: Lindsay Borvansky, Rachel Brown, PharmD, MPH, Ashley Cann, Andrea Funk, Donna Fausak, Liddy Knight, Kristin Delisi, NP, MSN, Michelle R. Rizzo, ELS, Patima Tanapat, PhD.

FACULTY DISCLOSURES

All faculty will present their disclosures prior to their live presentation.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education and Global Education Group do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

PRIVACY POLICY

When you participate in an online educational activity sponsored by Integrity Continuing Education, Inc., you will be asked for your name, degree(s), affiliation(s), street address, telephone number, fax number, and…(continued)

MINIMUM SYSTEM REQUIREMENTS

•  Adobe^® Flash^® Player 10 plug-in should be downloaded
• Click on the “Agree and install now” button after unchecking the optional McAfee Security Scan Plus

Click here for more information on minimum system requirements.

DISCLAIMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

PROVIDER STATEMENT

This CME activity is provided by Integrity Continuing Education.

This AANP activity is jointly provided by Global Education Group and Integrity Continuing Education.

SUPPORTER ACKNOWLEDGEMENT

This activity is supported by educational grants from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson; Biogen, Inc.; Genentech, a member of the Roche Group; and Novartis Pharmaceuticals Corporation.